BGI is a global, leading retained Executive and Board level search firm, exclusively focused in the Life Sciences industries.

Revolutionizing Metabolic and Neurological Health

BOLD Longevity Growth (BLG) is a newly launched growth-stage biotechnology fund under BOLD Capital, founded by longevity pioneers Peter Diamandis and Sergey Young. BLG focuses on translating deep biol ...

Botanical SoIution Inc. plans to become a major supplier of pharmaceutical grade QS-21, based on a proprietary biotechnology platform, to address the serious challenges presented by the imminent short ...

Breakthru Medicine recently closed a $60M Series A and is not currently seeking funding immediately but would be interested in Series B early discussions. We are interested in talking to pharma partne ...

Bridge is the market leader in determining the intrinsic value of early-stage assets, defining the corporate commercialization strategy in P2, developing the Commercialization Roadmap and go-to-market ...

Brilliance is an intellectual property platform built for the biotech ecosystem, helping innovators, IP owners, and investors unlock value from patents, license agreements, and royalty contracts. For ...

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

BVS provides effective & cost-saving vendor management services to life sciences companies to obtain the best products/services for their R&D. BVS also has implemented nationwide women empowerment pro ...

Cadenza Bio is a biotechnology company focused on developing a series of novel small-molecule drugs for the treatment of demyelinating and inflammatory diseases.